1-4 of 4
Stephanie Elkins, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An Expanded Treatment Protocol of Panobinostat Plus Bortezomib and Dexamethasone in Patients with Previously Treated Myeloma

Vincent L Hansen, MD, Morton Coleman, MD, Stephanie Elkins, MD, Jeffrey P. Letzer, Moshe Yair Levy, MD, Lasika Seneviratne, MD, Jessica Rine, Marina White, Emil T Kuriakose, MD
Journal: Blood
Blood (2015) 126 (23): 3027.
https://doi.org/10.1182/blood.V126.23.3027.3027
Published: 2015
Journal Articles

Southwest Oncology Group Study S0910: A Phase 2 Trial of Clofarabine/ Cytarabine/ Epratuzumab for Relapsed/ Refractory Acute Lymphocytic Leukemia.

Anjali Advani, MD, Shannon McDonough, Steven Coutre, MD, Brent L. Wood, MD, PhD, Jerald P. Radich, MD, Martha Mims, MD, Margaret O'Donnell, M.D., F.R.C.P.C., Stephanie Elkins, MD, Michael W. Becker, MD, Megan Othus, PhD, Frederick R. Appelbaum, MD
Journal: Blood
Blood (2012) 120 (21): 2603.
https://doi.org/10.1182/blood.V120.21.2603.2603
Published: 2012
Journal Articles

Reduced Intensity Conditioning Regimens with Alemtuzumab Result in Low Treatment-Related Mortality and Low Relapse Rate in Unrelated and Related Allotransplantation Recipients.

Carolyn L. Bigelow, MD, Stephanie Elkins, MD, Vincent Herrin, MD, Cheryl L. Hardy, PhD, Joe Clark Files, MD
Journal: Blood
Blood (2006) 108 (11): 5253.
https://doi.org/10.1182/blood.V108.11.5253.5253
Published: 2006
Journal Articles

Less Treatment Related Mortality with Variable Intensity Conditioning Than Non-Myeloablative Conditioning in Unrelated and Related Adult Allogeneic Transplant Recipients.

Carolyn L. Bigelow, MD, Stephanie Elkins, MD, Cheryl L. Hardy, PhD, Joe Clark Files, MD
Journal: Blood
Blood (2004) 104 (11): 5051.
https://doi.org/10.1182/blood.V104.11.5051.5051
Published: 2004